Full name
VOIGT CENTRUM OKULISTYCZNE ŁÓDŹ SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
VOIGT CENTRUM OKULISTYCZNE ŁÓDŹ SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. KWIATY POLNE 40, 32-087 BIBICE
TAX ID5130260127
Rate company:
VOIGT CENTRUM OKULISTYCZNE ŁÓDŹ SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID5130260127
KRS0000782714
Share capital18,000.00 zł
address
UL. KWIATY POLNE 40, 32-087 BIBICE
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
5130260127
REGON
383136665
KRS
0000782714
Legal form
limited liability company
Register Address
UL. KWIATY POLNE 40, 32-087 BIBICE
Date of registration in KRS
2019-04-17
Date of commencement of economic activity
2019-04-17
Act signature
KR.XII NS-REJ.KRS/16863/24/384/ADE
Pkd codes
86.22.Z - Specialist medical practice
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.74.Z - Retail sale of medical and orthopedic products
66.19.Z - Other activities supporting financial services, excluding insurance and pension funds
86.90.D - Healthcare
Payer VAT status
exempted
Vat list bank account(s)
PL47 1600 1198 1714 3055 2000 0001 
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2022 | 2023 | 2024 | ||
|---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Profit (loss) on sale  | -2,8 | -16 | -96,7 | -505,7 |
Gross profit (loss) | -2,9 | -16,2 | -115 | -610,2 |
EBITDA | -2,9 | -16,2 | -84,9 | -424 |
Short time liabilities | 0 | 0 | 246,9 | -∞ |
Other operating costs | 0 | 0,2 | 5 | 2078,6 |
Equity capital | 20,9 | 4,7 | -110,3 | -2450,7 |
Operating profit (EBIT) | -2,9 | -16,2 | -85,1 | -425,1 |
Assets | 20,9 | 4,7 | 713,9 | 15 107,6 |
Net profit (loss) | -2,9 | -16,2 | -115 | -610,2 |
Cash | 16,4 | 3,5 | 1,1 | -67,5 |
Net income from sale | 2,9 | 0 | 124,9 | -∞ |
Liabilities and provisions for liabilities | 0 | 0 | 824,2 | -∞ |
Working assets | 20,9 | 4,7 | 630,4 | 13 329,2 |
Other income costs | 0 | 0 | 16,7 | -∞ |
Depreciation | 0 | 0 | 0,2 | -∞ |
% | % | % | p.p. | |
Profitability of capital | -13,7 | -345,1 | 104,3 | 449,4 |
Equity capital to total assets | 99,9 | 100 | -15,5 | -115,5 |
Gross profit margin | -97,1 | -92,1 | 5 | |
EBITDA Margin | -97,1 | -68 | 29,1 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 | 0 | 722 | 722 |
Current financial liquidity indicator | 1229.97705078125 | 2.5532708168029785 | -1227,4 | |
Net dept to EBITDA | 5.740841388702393 | 0.21675965189933777 | -6.788281440734863 | -7 |
Financial statements
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
Med+reh Filip Pałczyński
Września